IP Verse

Zbm Patents Aps patent opposition analysis

The comprehensive analysis of Zbm Patents Aps opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Zbm Patents Aps

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3103443	Method For Treating Primary Insomnia	NEURIM PHARMACEUTICALS	Sep 30, 2021	ORIFARM GENERICS
EP3133070	Eliglustat (Genz 112638) As Inhibitor Of Glucosylceramide Synthase For Use In A Method Of Treating Fabry'S Or Gaucher'S Disease, The Method Comprising Adjusting The Individual Therapeutical Dose To The P-450 Metabolism Of The Patient	GENZYME	May 14, 2020	HETERO LABS
EP1441702	Method For Treating Primary Insomnia	NEURIM PHARMACEUTICALS	Apr 8, 2020	ORIFARM GENERICS
EP2854790	Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture Media	ARES TRADING	May 14, 2019	FERRING
EP2164877	The Puro-Dhfr Quadrifunctional Marker And Its Use In Protein Production	MERCK SERONO	Sep 4, 2018	FERRING

Top companies who are the clients of Zbm Patents Aps